超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

魯抗醫藥 Lukang Pharmaceutical 
山東魯抗醫藥股份有限公司是國家大型生物制藥企業，國家重要的抗生素研發、生產基地，國家重點高新技術企業，擁有國家級企業技術中心。魯抗醫藥A股（600789）股票于1997年2月在上海證券交易所掛牌上市，現有資產38億元，占地近4000畝，擁有5家全資子公司、7家控股子公司、1家參股公司，員工6500余人，其中各類專業技術人員3100余人。

魯抗以發展生態醫藥、服務人類健康為使命，以專業領先，行業領跑、基業長青為愿景，堅持誠信、創新、共贏的核心價值觀，大力創建資源節約型和環境友好型企業，制造安全高效的藥品，保障病患者健康，造福自然，造福人類。

魯抗醫藥擁有年產各類微生物發酵及半合成原料藥15000噸、粉針30億支、片劑100億片、膠囊50億粒、水針2億支、大容量注射劑1.5億瓶的生產能力，主要產品有人用藥、動植物藥等500余個品種，已通過ISO9001質量體系認證、ISO14000環境體系認證和OSHMS職業健康安全體系認證，青霉素鈉原料藥及粉針獲得國家質量金獎，酒石酸泰樂霉素、大觀霉素原料藥獲得歐盟CEP證書，大觀霉素通過德國cGMP認證，AIV、鹽酸大觀霉素均通過美國FDA認證。魯抗產品暢銷全國，遠銷亞洲、歐洲、非洲、美洲40多個國家和地區，年出口創匯過億美元。

魯抗以科技為先導，走科技興企之路，運用現代生物技術，生產經營抗生素類、氨基酸類、心腦血管類、半合成抗生素類原料藥，生物藥品以及相關制劑、輸液、中成藥、醫藥中間體、動物保健用抗生素、淀粉、葡萄糖等。

“魯抗”牌商標是“中國馳名商標”，被評為“商務部重點培育和發展的出口名牌”，先后獲得了“全國質量效益型先進企業”、“全國用戶滿意企業”、“全國醫藥優秀企業”等榮譽稱號，2009年被認定為國家級高新技術企業；2011年魯抗研發中心被認定為國家級企業技術中心，2012年被確定為山東省科技興貿出口創新基地。

“十二五”期間，魯抗圍繞發展戰略，以市場為導向，以體制機制和管理創新為保障，以科技創新和技術進步為動力，優化資源配置，提升管理能力，打造生物制藥、生物制品、生物基因制藥三條產業鏈，大力發展魯抗（人用）醫藥、魯抗動保、環境科技、魯抗生物四大板塊，建設魯抗醫藥、科技、生物制造、合成四大產業園區，努力培育和提升企業核心競爭力，使魯抗躋身于國內一流制藥企業行列。

As a large stated owned company and one of the major production bases for antibiotics in China, Shandong Lukang Pharmaceutical Group Co., Ltd. owns total assets of RMB 3.8 billion Yuan, 9 subsidiaries--one listed company on Shanghai Stock Exchange among them. Total employee is over 7000.

Lukang Pharma (formerly Jining Antibiotic Factory) was founded in 1966. In 1984, Director’s Responsibility System was adopted and was changed to stock share company in 1992. In 1997, Shandong Lukang Pharmaceutical Co., Ltd was listed on Shanghai Stock Exchange. Lukang Brand is China well-known trademark and was recognized by ShandongProvince as priority cultivation world famous brand. From 2001, Lukang was certified by ISO14001, OSHMS and GMP for all the workshops.In 2005, Lukang brand was recognized by the Ministry of Commerce of the People’s Republic of China as a “Chinese Export Brand for Priority Cultivation and Development”.

Major products of Lukang Pharma. are: antibiotics, semi-synthetic antibiotics and their finished products for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starch, glucose and amino acid. Its products have been exporting to more than 40 countries districts all over the world and annual exporting value is over USD40 milllion. By adjusting the composition of the products and optimized the product structure, three series of product chain for 6-APA, 7-ACA and 7-ADCA have been formed in Lukang and Lukang Pharma. has changed successfully from a traditional antibiotics plant to a semi-synthetic antibiotics manufacturer.

Facing the future and with a view to establish a long lasting great enterprise, Lukang Pharma. will devote itself to the career of human health care and contribute more and more to the society.